Transrectal versus transperineal prostate fusion biopsy: a pair-matched analysis to evaluate accuracy and complications

  1. Oderda, Marco ORCID logo
  2. Diamand, Romain
  3. Abou Zahr, Rawad
  4. Anract, Julien
  5. Assenmacher, Gregoire
  6. Barry Delongchamps, Nicolas
  7. Bui, Alexandre Patrick
  8. Benamran, Daniel
  9. Calleris, Giorgio
  10. Dariane, Charles
  11. Ferriero, Mariaconsiglia
  12. Fiard, Gaelle
  13. Taha, Fayek
  14. Fourcade, Alexandre
  15. Fournier, Georges
  16. Guenzel, Karsten
  17. Halinski, Adam
  18. Marra, Giancarlo
  19. Ploussard, Guillaume
  20. Rysankova, Katerina
  21. Roche, Jean-Baptiste
  22. Simone, Giuseppe
  23. Windisch, Olivier
  24. Gontero, Paolo

Download
00345_2024_Article_5245.pdf 907,06KB
WeightNameValue
1000 Titel
  • Transrectal versus transperineal prostate fusion biopsy: a pair-matched analysis to evaluate accuracy and complications
1000 Autor/in
  1. Oderda, Marco |
  2. Diamand, Romain |
  3. Abou Zahr, Rawad |
  4. Anract, Julien |
  5. Assenmacher, Gregoire |
  6. Barry Delongchamps, Nicolas |
  7. Bui, Alexandre Patrick |
  8. Benamran, Daniel |
  9. Calleris, Giorgio |
  10. Dariane, Charles |
  11. Ferriero, Mariaconsiglia |
  12. Fiard, Gaelle |
  13. Taha, Fayek |
  14. Fourcade, Alexandre |
  15. Fournier, Georges |
  16. Guenzel, Karsten |
  17. Halinski, Adam |
  18. Marra, Giancarlo |
  19. Ploussard, Guillaume |
  20. Rysankova, Katerina |
  21. Roche, Jean-Baptiste |
  22. Simone, Giuseppe |
  23. Windisch, Olivier |
  24. Gontero, Paolo |
1000 Verlag Springer Berlin Heidelberg
1000 Erscheinungsjahr 2024
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2024-09-25
1000 Erschienen in
1000 Quellenangabe
  • 42(1):535
1000 Copyrightjahr
  • 2024
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00345-024-05245-1 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11424653/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • <jats:title>Abstract</jats:title><jats:sec> <jats:title>Purpose</jats:title> <jats:p>To evaluate biopsy-related complications and detection rates of any PCa and clinically significant PCa (csPCa, intended as grade group ≥ 2) between MRI-targeted TP fusion biopsies (TPBx) and TR ones (TRBx).</jats:p> </jats:sec><jats:sec> <jats:title>Methods</jats:title> <jats:p>We performed a multicentric study on 4841 patients who underwent fusion biopsy between 2016 and 2023. A case–control matching was performed to find comparable cohorts of 646 TPBx and 646 TRBx. Mean T test and Pearson chi-square tests were used to compare continuous and categorical variables.</jats:p> </jats:sec><jats:sec> <jats:title>Results</jats:title> <jats:p>Baseline characteristics were comparable between the cohorts, except for target location with a higher rate of anterior lesions in TPBx group. Complications were rare and no difference was found between the groups, with similar rates of infections after TRBx and TPBx (N = 5 (0.8%) vs N = 2 (0.3%), p 0.45). All patients in TRBx and 90.1% in TPBx group received antibiotic prophylaxis. A higher csPCa detection rate was found in TPBx over the group (50.5% vs 36.2%, p &lt; 0.001). On average, positive targeted cores were increased in TPBx group, for any PCa (1.6 vs 1.4, p 0.04) and csPCa (1.0 vs 0.8, p 0.02). Among the limitations of study, we acknowledge the retrospective design and the possible under-reporting of complications.</jats:p> </jats:sec><jats:sec> <jats:title>Conclusions</jats:title> <jats:p>MRI-targeted fusion TPBx achieves a significantly higher csPCa detection than TRBx, with a diagnostic advantage for apical and anterior lesions. No significant differences were found in terms of complications that were rare in both groups, considering a widespread adoption of antibiotic prophylaxis.</jats:p> </jats:sec>
1000 Sacherschließung
lokal Prostate biopsy
lokal Image-Guided Biopsy/methods [MeSH]
lokal Aged [MeSH]
lokal Accuracy
lokal Humans [MeSH]
lokal Rectum [MeSH]
lokal Postoperative Complications/epidemiology [MeSH]
lokal Prostatic Neoplasms/pathology [MeSH]
lokal Retrospective Studies [MeSH]
lokal Transrectal
lokal Middle Aged [MeSH]
lokal Comparison
lokal Magnetic Resonance Imaging [MeSH]
lokal Complications
lokal Male [MeSH]
lokal Reproducibility of Results [MeSH]
lokal Matched-Pair Analysis [MeSH]
lokal Prostate/pathology [MeSH]
lokal Research
lokal Transperineal
lokal Fusion
lokal Case-Control Studies [MeSH]
lokal Image-Guided Biopsy/adverse effects [MeSH]
lokal Perineum [MeSH]
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0003-4681-888X|https://frl.publisso.de/adhoc/uri/RGlhbWFuZCwgUm9tYWlu|https://frl.publisso.de/adhoc/uri/QWJvdSBaYWhyLCBSYXdhZA==|https://frl.publisso.de/adhoc/uri/QW5yYWN0LCBKdWxpZW4=|https://frl.publisso.de/adhoc/uri/QXNzZW5tYWNoZXIsIEdyZWdvaXJl|https://frl.publisso.de/adhoc/uri/QmFycnkgRGVsb25nY2hhbXBzLCBOaWNvbGFz|https://frl.publisso.de/adhoc/uri/QnVpLCBBbGV4YW5kcmUgUGF0cmljaw==|https://frl.publisso.de/adhoc/uri/QmVuYW1yYW4sIERhbmllbA==|https://frl.publisso.de/adhoc/uri/Q2FsbGVyaXMsIEdpb3JnaW8=|https://frl.publisso.de/adhoc/uri/RGFyaWFuZSwgQ2hhcmxlcw==|https://frl.publisso.de/adhoc/uri/RmVycmllcm8sIE1hcmlhY29uc2lnbGlh|https://frl.publisso.de/adhoc/uri/RmlhcmQsIEdhZWxsZQ==|https://frl.publisso.de/adhoc/uri/VGFoYSwgRmF5ZWs=|https://frl.publisso.de/adhoc/uri/Rm91cmNhZGUsIEFsZXhhbmRyZQ==|https://frl.publisso.de/adhoc/uri/Rm91cm5pZXIsIEdlb3JnZXM=|https://frl.publisso.de/adhoc/uri/R3VlbnplbCwgS2Fyc3Rlbg==|https://frl.publisso.de/adhoc/uri/SGFsaW5za2ksIEFkYW0=|https://frl.publisso.de/adhoc/uri/TWFycmEsIEdpYW5jYXJsbw==|https://frl.publisso.de/adhoc/uri/UGxvdXNzYXJkLCBHdWlsbGF1bWU=|https://frl.publisso.de/adhoc/uri/UnlzYW5rb3ZhLCBLYXRlcmluYQ==|https://frl.publisso.de/adhoc/uri/Um9jaGUsIEplYW4tQmFwdGlzdGU=|https://frl.publisso.de/adhoc/uri/U2ltb25lLCBHaXVzZXBwZQ==|https://frl.publisso.de/adhoc/uri/V2luZGlzY2gsIE9saXZpZXI=|https://frl.publisso.de/adhoc/uri/R29udGVybywgUGFvbG8=
1000 Hinweis
  • DeepGreen-ID: 77212209dce7474c81059f6b2ffb0db4 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Förderer
  1. Università degli Studi di Torino |
1000 Fördernummer
  1. -
1000 Förderprogramm
  1. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Università degli Studi di Torino |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6517995.rdf
1000 Erstellt am 2025-07-05T08:07:07.929+0200
1000 Erstellt von 322
1000 beschreibt frl:6517995
1000 Zuletzt bearbeitet 2025-08-19T20:04:26.183+0200
1000 Objekt bearb. Tue Aug 19 20:04:26 CEST 2025
1000 Vgl. frl:6517995
1000 Oai Id
  1. oai:frl.publisso.de:frl:6517995 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source